CRY - CryoLife, Inc.
| Previous close | 18.20 |
| Open | 18.15 |
| Bid | 18.01 x 1000 |
| Ask | 19.85 x 800 |
| Day's range | 17.67 - 18.48 |
| 52-week range | 12.63 - 33.00 |
| Volume | 255,443 |
| Avg. volume | 342,033 |
| Market cap | 689.14M |
| Beta (5Y monthly) | 1.37 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.12 |
| Earnings date | 28 Jul 2020 - 03 Aug 2020 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 09 Dec 2015 |
| 1y target est | 26.80 |
- Motley Fool
CryoLife (CRY) Q1 2020 Earnings Call Transcript
It is now my pleasure to introduce your host, Lynn Lewis from Gilmartin Group. Joining me today from CryoLife's management team are Pat Mackin, CEO, and Ashley Lee, CFO. Comments made on this call that look forward in time involve risks and uncertainties and are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
- Zacks
CryoLife (CRY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
CryoLife (CRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Simply Wall St.
Should You Worry About CryoLife, Inc.'s (NYSE:CRY) CEO Salary Level?
In 2014 Pat MacKin was appointed CEO of CryoLife, Inc. (NYSE:CRY). This analysis aims first to contrast CEO...
- Zacks
Zacks.com featured highlights include: Carrols, Braskem, FirstService and CryoLife
Zacks.com featured highlights include: Carrols, Braskem, FirstService and CryoLife
- Zacks
5 Toxic Stocks to Disown or Play Short to Book Profits
Figuring out bloated toxic stocks on a regular basis and discarding them at the right time is the key to successful investing.
- Simply Wall St.
If You Had Bought CryoLife (NYSE:CRY) Shares Five Years Ago You'd Have Made 151%
CryoLife, Inc. (NYSE:CRY) shareholders might be concerned after seeing the share price drop 14% in the last quarter...
- GlobeNewswire
Cryptologic Releases 2019 Third Quarter Financial Results
TORONTO, Nov. 27, 2019 -- Cryptologic Inc. (“Cryptologic” or the “Company”) (CSE:CRY) today announces its financial results for the quarter ended September 30, 2019. Selected.
- Simply Wall St.
Are Investors Undervaluing CryoLife, Inc. (NYSE:CRY) By 21%?
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of CryoLife, Inc...
- Zacks
CryoLife (CRY) Q3 Earnings Top Estimates
CryoLife (CRY) delivered earnings and revenue surprises of 50.00% and -1.91%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Analysts Estimate CryoLife (CRY) to Report a Decline in Earnings: What to Look Out for
CryoLife (CRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Simply Wall St.
Why CryoLife, Inc.’s (NYSE:CRY) Return On Capital Employed Might Be A Concern
Today we'll evaluate CryoLife, Inc. (NYSE:CRY) to determine whether it could have potential as an investment idea. In...
- Simply Wall St.
These 4 Measures Indicate That CryoLife (NYSE:CRY) Is Using Debt Reasonably Well
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
- Zacks
CryoLife Enters Agreement With Endospan for Aortic Stent
CryoLife (CRY) eyes to expand the portfolio of aortic care, with endovascular stent graft system.
- GlobeNewswire
Cryptologic Releases 2019 Second Quarter Financial Results
TORONTO, Aug. 29, 2019 -- Cryptologic Inc. (“Cryptologic” or the “Company”) (CSE:CRY) today announces its financial results for the quarter ended June 30, 2019. Selected.
- Simply Wall St.
Should You Be Worried About CryoLife, Inc.'s (NYSE:CRY) 1.2% Return On Equity?
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
- Zacks
4 Toxic Stocks to Abandon or Sell Short for Solid Gains
Overhyped toxic stocks are vulnerable to external shocks and burdened with huge amount of debt.
- Motley Fool
CryoLife (CRY) Q2 2019 Earnings Call Transcript
CRY earnings call for the period ending June 30, 2019.
- Zacks
CryoLife (CRY) Surpasses Q2 Earnings and Revenue Estimates
CryoLife (CRY) delivered earnings and revenue surprises of 37.50% and 0.20%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
Is CryoLife, Inc.'s (NYSE:CRY) CEO Paid At A Competitive Rate?
In 2014 Pat MacKin was appointed CEO of CryoLife, Inc. (NYSE:CRY). This report will, first, examine the CEO...
